Smoking Cessation Drugs: World Market Prospects 2013-2023

  • September 2013
  • -
  • Visiongain
  • -
  • 138 pages

Report Details
Anti-smoking drug revenues will expand - you see what's most likely to succeed

How much revenue can medicines to treat smoking generate? Visiongain's updated report gives you predictions, helping you stay ahead. There you see financial results, R&D trends, opportunities, and commercial potential.

In that new study you discover forecasted sales to 2023 at overall world market, submarket, product, and national level. You also assess technologies, competition, and expected developments for treating tobacco addiction. Find prospects there.

Read on to explore those products and see what their future market could be worth.

Forecasts from 2013-2023 and other analyses to help you find opportunities

Besides revenue forecasting to 2023, our analysis shows recent results, growth rates, and market shares. There you discover original analysis, seeing commercial outlooks and developments (R&D). You also get 60 tables, 36 charts, and four interviews.

Discover what's happening in that industry, using our report to find data you need

In that study you hear what's happening for smoking medications, learning where needs and money exist. Try our report now, seeing how you and your organisation can gain.

Avoid falling behind, missing business or losing influence. Instead, discover information you need to stay ahead. Our work explains, helping your research, analyses, and decisions.

The following sections, then, show what you get in that new investigation.

Sales predictions for the world market and submarkets

Discover in our report overall world revenue to 2023 for smoking-cessation drugs. You also find individual revenue forecasts for therapeutic submarkets at world level:
• Over-the-counter medicines (OTC)
• Prescription drugs (Rx)
• Nicotine replacement therapies (NRT)
• Nicotine receptor partial agonists (NRPA)
• Antidepressants.

How will sales of those therapies expand? Which classes of treatments will generate most money? There you assess prospects for revenue growth, seeing where you can benefit.

You also discover sales predictions by agent, seeing how they can succeed.

Revenue predictions for top products - see what's possible

How will those anti-addiction medicines perform to 2023 at world level? Our report forecasts individual revenues of six leading brands:
• Champix/Chantix
• NiQuitin/Nicabate/NicoDerm CQ
• Nicorette
• Nicotinell
• Zyban
• Tabex.

There, from 2013, you discover how high sales can go. Investigate opportunity. You see what's happening, then, understanding challenges, trends, competitors, and opportunities.

You find geographical revenue predictions too.

National markets - where will highest revenues and growth occur?

In developed and developing countries, anti-smoking therapy will give opportunities to pharmaceutical companies. You see where and how, from 2013, understanding potential.

In our study you find individual revenue forecasts to 2023 for 11 national markets:
• United States (US)
• Japan
• EU leaders - Germany, France, the UK, Italy, and Spain (EU5)
• BRIC countries - Brazil, Russia, India, and China.

There you find countries with highest revenues and potential sales growth. Our work explains. You see the future of those products, appraising progress and discovering what it means, including emerging trends.

Issues affecting developers, producers, and sellers of anti-smoking medicines

The report explains forces affecting that industry and market from 2013, including these:
• Nicotine vaccines
• Monoamine oxidase inhibitors
• Cannabinoid receptor-1 antagonists
• Dopamine D3 antagonists
• Opiate antagonists
• Other smoking cessation aids in testing.

There you assess research and development (R&D), finding advances and outlooks for b

Table Of Contents

1. Executive Summary

1.1 Smoking Cessation Drugs: World Market Overview
1.2 Aims and Format of the Report
1.3 Research and Analysis Methods
1.4 Scope of the Report

2. Introduction to Smoking Cessation

2.1 Tobacco- What is All the Fuss About?
2.1.1 How is Tobacco Consumed?
2.1.2 Tobacco Smoking is a Major Challenge for Healthcare Worldwide
2.2 Smoking Causes Many Health Disorders
2.3 Nicotine Addiction is at the Root of Smoking
2.4 Smoking Cessation
2.4.1 Why is it Difficult to Stop Smoking?
2.4.2 How Can Smokers Quit?

3. World Smoking Cessation Drugs Market, 2013-2023

3.1 How Will the Smoking Cessation Market Develop Until 2023?
3.2 Smoking Cessation Drugs Market by Type of Sale
3.2.1 Over-the-Counter (OTC) Smoking Cessation Drugs, 2012
3.2.1.1 OTC Smoking Cessation Drugs: Forecast, 2013-2023
3.2.2 Prescription (Rx) Smoking Cessation Drugs, 2012
3.2.2.1 Prescription Smoking Cessation Drugs: Forecast, 2013-2023
3.3 Smoking Cessation Drugs by Mechanism of Action
3.3.1 Nicotine Replacement Therapy
3.3.1.1 Nicotine Replacement Therapy, 2012
3.3.1.2 Nicotine Replacement Therapy Forecast, 2013-2023
3.3.2 Nicotine Receptor Partial Agonist Drugs
3.3.2.1 Nicotine Receptor Partial Agonist Drugs, 2012
3.3.2.2 Nicotine Receptor Partial Agonist Drugs Forecast, 2013-2023
3.3.3 Antidepressants
3.3.3.1 Antidepressants for Smoking Cessation, 2012
3.3.3.2 Antidepressants for Smoking Cessation: Forecast, 2013-2023

4. Leading National Markets for Smoking Cessation Drugs to 2023

4.1 Major Geographical Markets for the Smoking Cessation Industry in 2012
4.2 The US is Still the Market Leader
4.2.1 Smoking Prevalence Declining in the US
4.2.2 Availability and Reimbursement of Smoking Cessation Aids in the US
4.2.3 US Smoking Cessation Market Revenue, 2012
4.2.4 US Smoking Cessation Market Forecast, 2013-2023
4.2.5 Scope for US Smoking Cessation Market Expansion
4.3 The Japanese Smoking Cessation Market has Potential to Expand in Revenues
4.3.1 Japan has a Less Developed Smoking Cessation Market
4.3.2 The Japanese Smoking Cessation Market, 2012
4.3.3 Japanese Smoking Cessation Market Forecast, 2013-2023
4.4 The EU-5 Smoking Cessation Drugs Market
4.4.1 The UK Smoking Cessation Market
4.4.1.1 Tobacco Use in the UK
4.4.1.2 The UK Pioneers Smoking Cessation Reimbursement and General Sales OTC Retailing of NRT
4.4.1.3 The UK has Strong Anti-Smoking Legislation
4.4.1.4 UK Smoking Cessation Market, 2012
4.4.1.5 UK Smoking Cessation Market Forecast, 2013-2023
4.4.2 The French Smoking Cessation Market
4.4.2.1 Tobacco Use in France is Still High
4.4.2.2 The French Smoking Cessation Market, 2012
4.4.2.3 French Smoking Cessation Market Forecast, 2013-2023
4.4.2.4 Factors Influencing the Development of the French Market
4.4.3 The Spanish Smoking Cessation Market
4.4.3.1 Tobacco Use in Spain is Low
4.4.3.2 The Spanish Smoking Cessation Market, 2012
4.4.3.3 The Spanish Smoking Cessation Market Forecast, 2013-2023
4.4.3.4 Spain's Anti-smoking Laws are Very Robust
4.4.4 The Italian Smoking Cessation Market
4.4.4.1 Reducing Tobacco Use in Italy is a Government Priority
4.4.4.2 The Italian Smoking Cessation Market, 2012
4.4.4.3 The Italian Smoking Cessation Market Forecast, 2013-2023
4.4.4.4 Italy has a Decades-Long Commitment to Reducing Smoking
4.4.5 The German Smoking Cessation Market
4.4.5.1 Germany is a Smoker's Citadel
4.4.5.2 The German Smoking Cessation Market, 2012
4.4.5.3 German Smoking Cessation Market Forecast, 2013-2023
4.4.5.4 Germany Has a Relaxed Attitude to Smoking
4.5 The BRIC Smoking Cessation Drugs Market is Untapped
4.5.1 The Brazilian Smoking Cessation Market
4.5.1.1 Tobacco Use in Brazil is Pervasive
4.5.1.2 The Brazilian Smoking Cessation Market, 2012
4.5.1.3 Brazilian Smok

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers

PharmaPoint: Asthma - Global Drug Forecast and Market Analysis to 2023

PharmaPoint: Asthma - Global Drug Forecast and Market Analysis to 2023

  • $ 10 995
  • Industry report
  • August 2014
  • by Global Data

PharmaPoint: Asthma - Global Drug Forecast and Market Analysis to 2023 Summary Asthma accounts for approximately 250,000 deaths around the world annually, deaths that otherwise could be easily prevented ...

Cancer Vaccines: Technologies and Global Markets

Cancer Vaccines: Technologies and Global Markets

  • $ 6 650
  • Industry report
  • Dec 2014
  • by BCC Research

REPORT HIGHLIGHTS The global market for cancer vaccines was about $4.5 billion in 2013. This market reached about $4.0 billion in 2014 and is expected to reach $4.3 billion in 2019, registering a compound ...

Global Pediatric Drugs and Vaccines Market

Global Pediatric Drugs and Vaccines Market

  • $ 4 950
  • Industry report
  • September 2014
  • by Global Industry Analysts

This report analyzes the worldwide markets for Pediatric Drugs and Vaccines in US$ Million by the following Therapeutic Class: Pediatric Vaccines, Pediatric Hormones, Allergy & Respiratory Drugs, Anti-infective ...


2 Companies

Company Profiles

Novartis Inc.

Switzerland

Array Biopharma Inc.

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.